1. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial. Issue 1 (15th May 2020) Authors: D'Angelo, Sandra P; Bhatia, Shailender; Brohl, Andrew S; Hamid, Omid; Mehnert, Janice M; Terheyden, Patrick; Shih, Kent C; Brownell, Isaac; Lebbé, Celeste; Lewis, Karl D; Linette, Gerald P; Milella, Michele; Georges, Sara; Shah, Parantu; Ellers-Lenz, Barbara; Bajars, Marcis; Güzel, Gülseren; Nghi... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study. Issue 7 (23rd July 2021) Authors: D'Angelo, Sandra P; Lebbé, Celeste; Mortier, Laurent; Brohl, Andrew S; Fazio, Nicola; Grob, Jean-Jacques; Prinzi, Natalie; Hanna, Glenn J; Hassel, Jessica C; Kiecker, Felix; Georges, Sara; Ellers-Lenz, Barbara; Shah, Parantu; Güzel, Gülseren; Nghiem, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Issue 1 (January 2022) Authors: Naranbhai, Vivek; Viard, Mathias; Dean, Michael; Groha, Stefan; Braun, David A; Labaki, Chris; Shukla, Sachet A; Yuki, Yuko; Shah, Parantu; Chin, Kevin; Wind-Rotolo, Megan; Mu, Xinmeng Jasmine; Robbins, Paul B; Gusev, Alexander; Choueiri, Toni K; Gulley, James L; Carrington, Mary Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗